New eye drop aims to zap dry eye discomfort in weeks
NCT ID NCT07268599
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether Acoltremon 0.003% eye drops can quickly relieve symptoms like burning, irritation, and blurriness in people with moderate-to-severe dry eye disease. Fifty adults will use the drops as directed and report their symptom changes over 28 days. The goal is to see how fast and effectively the treatment eases discomfort.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Acoltremon 0.003% eye drops
- What this could lead to
- If successful, this could offer a fast-acting option to ease dry eye symptoms like burning, irritation, and blurriness.
- What could go wrong
- This is a small, early-phase trial with only 50 participants and no placebo group, so results may not be conclusive or widely applicable.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE (DED) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Colvard-Kandavel Eye Center
Encino, California, 91316, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can acne drug harm the eyes? new study investigates
- Which eye drop wins the dry eye battle? a Head-to-Head test
- Can a new eye drop soothe dry eye? a trial puts TRYPTYR to the test
- New eye drop aims to soothe dryness after cataract surgery
- Can simple eye drops soothe dry eyes? new study puts OTC brands to the test
- New eye drop hopes to soothe dry eye sufferers